EMA Approves Second CRISPR Therapy for Sickle Cell Disease in Europe
The decision expands patient access beyond the United States and sets reimbursement negotiations across France, Germany, and the UK.
Zara Hussain
May 8·about 1 month ago·7 min read
Credence Wire Journalist
Zara Hussain
Biotech & Life Sciences Reporter
Reports on CRISPR, longevity science, synthetic biology, and the coming convergence of AI and drug discovery. Based in San Francisco.
Articles by Zara
2 stories
TAME Trial Suggests Metformin Slows Age-Related Disease Progression
A decade-long study finds modest reductions in cardiovascular events among prediabetic adults — fueling longevity investment.
Zara Hussain
Mar 18·3 months ago·7 min read
Free Morning Briefing
Start your day with Credence Wire.
A calm, intelligent briefing delivered daily before the market opens.
Free. No spam. Unsubscribe anytime.